The Food and Drug Administration is changing how it handles COVID-19 vaccines starting this fall, limiting access to older ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

The agency told vaccine makers that COVID-19 vaccines used in the United States starting in fall 2025 should be based on JN.1 ...

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

World Health Organization (WHO) member countries adopted a new treaty on May 20, 2025, to improve international coordination ...

I'm a clinical academic, which is quite a rare breed of doctor, because what I'm doing, along with other clinical academics, ...

And with Trump, men like Musk are guiding US domestic and foreign policies in eugenicist and longtermist ways, leaving millions in actual or potential peril. Perhaps the leading example of old-style ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults.

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

Preliminary data from researchers in China suggest the NB.1.8.1 variant is not better at evading the immune system compared ...